posted on 2024-12-18, 07:20authored byZhaoxiang Cai, Rebecca C. Poulos, Adel Aref, Phillip J. Robinson, Roger R. Reddel, Qing Zhong
Evaluation metrics
History
ARTICLE ABSTRACT
DeePathNet integrates cancer-specific biological pathways using transformer-based deep learning for enhanced cancer analysis. It outperforms existing models in predicting drug responses, cancer types, and subtypes. By enabling pathway-level biomarker discovery, DeePathNet represents a significant advancement in cancer research and could lead to more effective treatments.